世界のニードルフリー注入機器市場:医療機器パイプライン分析2016

◆英語タイトル:Needle Free Injections - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0178EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年5月1日
◆ページ数:64
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、ニードルフリー注入機器のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・ニードルフリー注入機器の概要
・ニードルフリー注入機器の開発動向:開発段階別分析
・ニードルフリー注入機器の開発動向:セグメント別分析
・ニードルフリー注入機器の開発動向:領域別分析
・ニードルフリー注入機器の開発動向:規制Path別分析
・ニードルフリー注入機器の開発動向:承認日(推定)別分析
・企業別ニードルフリー注入機器の開発動向(パイプライン製品、進行中の治験)
・ニードルフリー注入機器の最近動向
【レポートの概要】

Needle Free Injections – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “Needle Free Injections – Medical Devices Pipeline Assessment, 2016″ provides an overview of Needle Free Injections currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Needle Free Injections pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Needle Free Injections under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Needle Free Injections and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Needle Free Injections under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Needle Free Injections Overview 6
3 Products under Development 7
3.1 Needle Free Injections – Pipeline Products by Stage of Development 7
3.2 Needle Free Injections – Pipeline Products by Territory 8
3.3 Needle Free Injections – Pipeline Products by Regulatory Path 9
3.4 Needle Free Injections – Pipeline Products by Estimated Approval Date 10
4 Needle Free Injections – Pipeline Products under Development by Companies 11
4.1 Needle Free Injections Companies – Pipeline Products by Stage of Development 11
4.2 Needle Free Injections – Pipeline Products by Stage of Development 12
5 Needle Free Injections Companies and Product Overview 13
5.1 B. Braun Melsungen AG Company Overview 13
5.1.1 B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview 13
5.2 Bioject Medical Technologies Inc. Company Overview 15
5.2.1 Bioject Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Boston Scientific Corporation Company Overview 21
5.3.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 Crossject SA Company Overview 23
5.4.1 Crossject SA Pipeline Products & Ongoing Clinical Trials Overview 23
5.5 Enable Injections, LLC Company Overview 29
5.5.1 Enable Injections, LLC Pipeline Products & Ongoing Clinical Trials Overview 29
5.6 Eternity Healthcare Inc. Company Overview 31
5.6.1 Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.7 EuroJet Medical Kft. Company Overview 32
5.7.1 EuroJet Medical Kft. Pipeline Products & Ongoing Clinical Trials Overview 32
5.8 Glide Pharmaceutical Technologies Limited Company Overview 33
5.8.1 Glide Pharmaceutical Technologies Limited Pipeline Products & Ongoing Clinical Trials Overview 33
5.9 Medical International Technologies (Mit Canada) Inc. Company Overview 35
5.9.1 Medical International Technologies (Mit Canada) Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.10 PharmaJet, Inc. Company Overview 41
5.10.1 PharmaJet, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.11 Teva Pharmaceutical Industries Limited Company Overview 42
5.11.1 Teva Pharmaceutical Industries Limited Pipeline Products & Ongoing Clinical Trials Overview 42
5.12 Vaxxas Pty. Ltd. Company Overview 44
5.12.1 Vaxxas Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 44
6 Needle Free Injections- Recent Developments 45
6.1 Apr 19, 2016: Rodney D. Altman, MD Joins Valeritas Board of Directors 45
6.2 Mar 21, 2016: ICU Medical Enters into Distribution Agreement with B. Braun Melsungen 45
6.3 Mar 15, 2016: Aradigm Announces Fourth Quarter 2015 and Full Year Financial Results 45
6.4 Mar 14, 2016: Inovio Pharma to Acquire Assets of Bioject Medical Technologies for USD5.5 Million 47
6.5 Mar 10, 2016: Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2015 Financial Results 47
6.6 Jan 07, 2016: Corporate Flu Clinics Offering PharmaJet Needle-Free Flu Shots 48
6.7 Dec 09, 2015: Crossject Enters into Agreement with Xi’an Xintong Pharma 49
6.8 Nov 16, 2015: Allmed Acquires Majority Stake in Pronefro-Produtos 49
6.9 Nov 12, 2015: Intermountain Healthcare Enters into Agreement with Velano Vascular 49
6.10 Nov 09, 2015: Zogenix Provides Update and Reports Third Quarter 2015 Financial Results 49
6.11 Oct 06, 2015: Rx Safes Enters into Distribution Agreement with Mika Medical and MK Global 51
6.12 Oct 05, 2015: Medicom receives the growth award – Borsen Gazelle 2015 52
6.13 Sep 14, 2015: Crossject Enters into Agreement with Sayre Therapeutics 52
6.14 Sep 09, 2015: Enable Injections Completes Its First-In-Human Wearable Injector Pilot Trial 52
6.15 Aug 20, 2015: PharmaJet Needle-Free Injector Becomes Part of the American Pharmacists Association Educational Curriculum 53
6.16 Aug 13, 2015: Aradigm Announces Second Quarter 2015 Financial Results 53
6.17 Aug 10, 2015: Zogenix Provides Corporate Update and Reports Second Quarter 2015 Financial Results 54
6.18 Jul 28, 2015: Zogenix Raises USD98.3 Million in Public Offering of Shares 56
6.19 Jul 16, 2015: CROSSJECT confirms the development plan for ZENEO Sumatriptan 56
6.20 Jul 06, 2015: Zogenix Expands Senior Leadership Team to Further Drive Strategic Focus on CNS Disorders and Orphan Drug Development 57
6.21 Jun 22, 2015: Biocorp Production Raises USD9.8 Million in IPO 57
6.22 Jun 22, 2015: Owen Mumford Expands Global Foot Print to Support Asia Pacific 58
6.23 May 11, 2015: Aradigm Announces First Quarter 2015 Financial Results 58
6.24 May 11, 2015: Zogenix Provides Corporate Update and Reports First Quarter 2015 Financial Results 59
7 Appendix 61
7.1 Methodology 61
7.2 About GlobalData 63
7.3 Contact Us 64
7.4 Disclaimer 64

1.1 List of Tables
Table 1: Needle Free Injections - Pipeline Products by Stage of Development 7
Table 2: Needle Free Injections - Pipeline Products by Territory 8
Table 3: Needle Free Injections - Pipeline Products by Regulatory Path 9
Table 4: Needle Free Injections - Pipeline Products by Estimated Approval Date 10
Table 5: Needle Free Injections Companies - Pipeline Products by Stage of Development 11
Table 6: Needle Free Injections - Pipeline Products by Stage of Development 12
Table 7: B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview 13
Table 8: Needle-Free System - Product Status 14
Table 9: Needle-Free System - Product Description 14
Table 10: Bioject Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
Table 11: Iject R Pre-Filled Syringe - Product Status 16
Table 12: Iject R Pre-Filled Syringe - Product Description 16
Table 13: Intradermal Pen Injector - Product Status 17
Table 14: Intradermal Pen Injector - Product Description 17
Table 15: Intradermal Syringe - Product Status 18
Table 16: Intradermal Syringe - Product Description 18
Table 17: Mega Jet - Product Status 19
Table 18: Mega Jet - Product Description 19
Table 19: Multi-Port Orifices - Product Status 20
Table 20: Multi-Port Orifices - Product Description 20
Table 21: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 21
Table 22: JetTouch System - Overactive Bladder - Product Status 22
Table 23: JetTouch System - Overactive Bladder - Product Description 22
Table 24: Crossject SA Pipeline Products & Ongoing Clinical Trials Overview 23
Table 25: Zeneo ID Human Needle-Free Injection Device - Product Status 24
Table 26: Zeneo ID Human Needle-Free Injection Device - Product Description 24
Table 27: Zeneo IM 0.5ml Needle - Free Injection Device - Product Status 25
Table 28: Zeneo IM 0.5ml Needle - Free Injection Device - Product Description 25
Table 29: Zeneo SC 0.5ml Needle-Free Injection Device - Product Status 26
Table 30: Zeneo SC 0.5ml Needle-Free Injection Device - Product Description 26
Table 31: Zeneo SC 0.8ml Needle-Free Injection Device - Product Status 27
Table 32: Zeneo SC 0.8ml Needle-Free Injection Device - Product Description 27
Table 33: Zeneo SC High Viscosity Needle-Free Injection Device - Product Status 28
Table 34: Zeneo SC High Viscosity Needle-Free Injection Device - Product Description 28
Table 35: Enable Injections, LLC Pipeline Products & Ongoing Clinical Trials Overview 29
Table 36: Wearable Enable Injector - Product Status 30
Table 37: Wearable Enable Injector - Product Description 30
Table 38: Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
Table 39: Multi Channel Needle-Free Injection Device - Product Status 31
Table 40: Multi Channel Needle-Free Injection Device - Product Description 31
Table 41: EuroJet Medical Kft. Pipeline Products & Ongoing Clinical Trials Overview 32
Table 42: Third Generation E-Jet 500 Needle Free Injector - Product Status 32
Table 43: Third Generation E-Jet 500 Needle Free Injector - Product Description 32
Table 44: Glide Pharmaceutical Technologies Limited Pipeline Products & Ongoing Clinical Trials Overview 33
Table 45: Glide SDI - Product Status 34
Table 46: Glide SDI - Product Description 34
Table 47: Medical International Technologies (Mit Canada) Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
Table 48: MED-JET MBX Injector - Product Status 36
Table 49: MED-JET MBX Injector - Product Description 36
Table 50: MIT-H-III - Product Status 37
Table 51: MIT-H-III - Product Description 37
Table 52: MIT-H-IV-1 - Product Status 38
Table 53: MIT-H-IV-1 - Product Description 38
Table 54: MIT-H-IV-5 - Product Status 39
Table 55: MIT-H-IV-5 - Product Description 39
Table 56: MIT-H-VI Dental Injector - Product Status 40
Table 57: MIT-H-VI Dental Injector - Product Description 40
Table 58: PharmaJet, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
Table 59: Variable Volume Drug Delivery Device - Product Status 41
Table 60: Variable Volume Drug Delivery Device - Product Description 41
Table 61: Teva Pharmaceutical Industries Limited Pipeline Products & Ongoing Clinical Trials Overview 42
Table 62: MicroDose Needlefree System - Product Status 43
Table 63: MicroDose Needlefree System - Product Description 43
Table 64: Vaxxas Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 44
Table 65: Nanopatch - Product Status 44
Table 66: Nanopatch - Product Description 44
Table 67: Glossary 62

1.2 List of Figures
Figure 1: Needle Free Injections - Pipeline Products by Stage of Development 7
Figure 2: Needle Free Injections - Pipeline Products by Territory 8
Figure 3: Needle Free Injections - Pipeline Products by Regulatory Path 9
Figure 4: Needle Free Injections - Pipeline Products by Estimated Approval Date 10

【掲載企業】

B. Braun Melsungen AG
Bioject Medical Technologies Inc.
Boston Scientific Corporation
Crossject SA
Enable Injections, LLC
Eternity Healthcare Inc.
EuroJet Medical Kft.
Glide Pharmaceutical Technologies Limited
Medical International Technologies (Mit Canada) Inc.
PharmaJet, Inc.
Teva Pharmaceutical Industries Limited
Vaxxas Pty. Ltd.

【レポートのキーワード】

ニードルフリー注入機器

★調査レポート[世界のニードルフリー注入機器市場:医療機器パイプライン分析2016]販売に関する免責事項
★調査レポート[世界のニードルフリー注入機器市場:医療機器パイプライン分析2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆